ASCO Issues New Metastatic Prostate Cancer Treatment Guide ASCO Issues New Metastatic Prostate Cancer Treatment Guide
Adding docetaxel or abiraterone to ADT improves metastatic prostate cancer survival, with patient and cost factors the most important considerations when choosing between them, say guidelines.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Docetaxel | Health | Hematology | Prostate Cancer | Taxotere